FSNN NEWS FUSION TO ASSUME BROADVOX PARTNER CONTRACTS;

New Post Public Reply Private Reply Replies (0) Message Board
iftheresaway
FSNN NEWS

FUSION TO ASSUME BROADVOX PARTNER CONTRACTS; BROADVOX TO FOCUS ON WHOLESALE

September 20, 2013By Khali Henderson 0 Comments

Posted in  News ,  M&A ,  Cloud Services ,  Channel Partner ,  Contracts/Agreements ,  Channel Programs , Agent/Subagent/Master Agent ,  Wholesale Services ,  IP Communications/Networks

Print

**Editor's Note: Please click here for a recap of the biggest channel-impacting mergers in Q2 2013.**

Cloud provider Fusion Telecommunications International Inc. told Channel Partners that it will acquire the agent agreements along with other assets of Dallas-based Broadvox LLC's retail cloud business. Meanwhile, Broadvox confirmed that its post-sale plans are to be a wholesale-only provider.

Fusion announced last week that it would pay $32.1 million for the Broadvox assets, which it plans to integrate with its NBS Business Services division, which was formed following its acquisition of Network Billing Systems in fall 2012.

Fusion CEO Matthew Rosen said NBS and Broadvox assets will be combined into one entity, but the final branding has yet to be determined. Fusion, the parent company, will continue to focus on wholesale carrier services internationally, he said.

As part of the transaction, Fusion will acquire Broadvox's Genband (Nortel) and Broadsoft hosted UC platforms as well as its proprietary SIP trunking platform. These will be added to NBS's existing proprietary platforms for hosted VoIP and SIP trunking services.

In addition, Fusion will acquire 5,800 Broadvox customers, for a combined retail customer base of more than 10,000, Rosen said.  It also will be bringing on Broadvox's retail-focused employees, which Rosen estimated to be more than 100 people.

Finally, the company expects to assume  all of Broadvox's agency agreements. He was uncertain of the total number, but said about 300 are active agents. NBS has more than 200 active agents, and Rosen estimated the cross-over to be minimal -- less than 5 percent.

Rosen said between Fusion and NBS, the company has more than 20 years of experience in the channel as well as the systems and processes needed to support indirect sales. He expects Broadvox partners will operate under their existing agreements until the combined company determines what will work best for the channel going forward.

Rosen told Channel Partners that his goal is to make sure the integration goes well and counted the channel among his top three priorities along with customers and employees.

Fusion/NBS does have a direct sales force, but Rosen said these representatives primarily are focused on specific verticals, such as health care. With Broadvox assets and expertise, he said the company can add legal to its vertical specializations.

With its retail business sold to Fusion, Broadvox intends to return to its wholesale roots, serving carriers, MVNOs, web companies and others in need of IP communications services, said Broadvox CMO Arnaud Gautier in an interview with Channel Partners.

Broadvox launched in 2001 as a provider of wholesale VoIP services to telecommunications carriers. It established a nationwide IP network and became one of the go-to carriers’ carriers for VoIP origination and termination services. It began offering commercial SIP trunking services in 2007. It later added hosted VoIP and then acquired cloud communications company Cypress Communications in 2011 .

Fusion Connect, Inc. (FSNNQ) Stock Research Links

FSNNQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading